JP2015501787A5 - - Google Patents

Download PDF

Info

Publication number
JP2015501787A5
JP2015501787A5 JP2014540198A JP2014540198A JP2015501787A5 JP 2015501787 A5 JP2015501787 A5 JP 2015501787A5 JP 2014540198 A JP2014540198 A JP 2014540198A JP 2014540198 A JP2014540198 A JP 2014540198A JP 2015501787 A5 JP2015501787 A5 JP 2015501787A5
Authority
JP
Japan
Prior art keywords
compound
hydrogen
composition
formula
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014540198A
Other languages
English (en)
Japanese (ja)
Other versions
JP6144688B2 (ja
JP2015501787A (ja
Filing date
Publication date
Priority claimed from US13/669,207 external-priority patent/US9084800B2/en
Application filed filed Critical
Publication of JP2015501787A publication Critical patent/JP2015501787A/ja
Publication of JP2015501787A5 publication Critical patent/JP2015501787A5/ja
Application granted granted Critical
Publication of JP6144688B2 publication Critical patent/JP6144688B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014540198A 2011-11-07 2012-11-06 インドールアルキルアミノ−ウィタステロイド複合体および使用方法 Expired - Fee Related JP6144688B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161556603P 2011-11-07 2011-11-07
US61/556,603 2011-11-07
US13/669,207 2012-11-05
US13/669,207 US9084800B2 (en) 2011-11-07 2012-11-05 Indolealkylamino-withasteroid conjugates and method of use
PCT/US2012/063727 WO2013070619A1 (en) 2011-11-07 2012-11-06 Indolealkylamino-withasteroid conjugates and method of use

Publications (3)

Publication Number Publication Date
JP2015501787A JP2015501787A (ja) 2015-01-19
JP2015501787A5 true JP2015501787A5 (enExample) 2015-10-29
JP6144688B2 JP6144688B2 (ja) 2017-06-07

Family

ID=48223848

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014540198A Expired - Fee Related JP6144688B2 (ja) 2011-11-07 2012-11-06 インドールアルキルアミノ−ウィタステロイド複合体および使用方法

Country Status (7)

Country Link
US (2) US9084800B2 (enExample)
EP (1) EP2776462B1 (enExample)
JP (1) JP6144688B2 (enExample)
CN (1) CN103917558B (enExample)
BR (1) BR112014010868B1 (enExample)
CA (1) CA2854631C (enExample)
WO (1) WO2013070619A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105503990A (zh) * 2015-12-29 2016-04-20 吴金凤 一种新的睡加内酯类化合物及其制备方法和医药用途
WO2018156202A1 (en) 2017-02-27 2018-08-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Anti-psychotic composition and treatment methods
CN119631978B (zh) * 2024-12-18 2026-06-30 云南洛宇生物科技有限公司 一种树鼩阿尔兹海默症造模方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2494698A1 (fr) * 1980-11-21 1982-05-28 Roussel Uclaf Nouveaux derives steroides 3-amino substitues, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
US5403851A (en) 1994-04-05 1995-04-04 Interneuron Pharmaceuticals, Inc. Substituted tryptamines, phenalkylamines and related compounds
US6153198A (en) * 1999-07-13 2000-11-28 Natreon Inc. Withania somnifera composition
EP1421198A4 (en) * 2001-06-26 2006-08-30 New York State Office Of Menta SCREENING METHODS WITH HIGH CYCLE-BASED FLOW
US6713092B1 (en) * 2002-12-03 2004-03-30 Natreon Inc. Withania Somnifera composition, method for obtaining same and pharmaceutical, nutritional and personal care formulations thereof
US20050266100A1 (en) * 2004-03-30 2005-12-01 Council Of Scientific And Industrial Research Rafi Marg Process isolation of withaferin-A from plant materials and products therefrom
US20070036873A1 (en) 2005-07-27 2007-02-15 Shibnath Ghosal Method of treatment or management of stress
JP2009541423A (ja) * 2006-06-23 2009-11-26 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ コリンエステラーゼ阻害剤と5‐ht6レセプター親和性の化合物との組合せ
JP5704484B2 (ja) 2008-03-06 2015-04-22 独立行政法人産業技術総合研究所 アシュワガンダ葉水抽出物を有効成分として含む組成物及びその製造方法
WO2010030395A2 (en) 2008-09-15 2010-03-18 Whitehead Institute For Biomedical Research Withaferin a analogs and uses thereof

Similar Documents

Publication Publication Date Title
EP3363797A8 (en) Oral dosage form of apoptosis signal-regulating kinase inhibitors
PH12013500301A1 (en) Oxadiazole inhibitors of leukotriene production
UA108369C2 (uk) Піролопіримідини як інгібітори cdk4/6
HK1215256A1 (zh) 用作吲哚胺2,3-二氧化酶的抑制劑的化合物
MX357305B (es) Compuestos y composiciones para inhibir la actividad de abl-1, abl-2, y bcr-abl1.
WO2013009701A3 (en) Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
NZ734152A (en) Compounds, compositions and methods useful for cholesterol mobilisation
MX336051B (es) Diarilacetileno hidracido que contiene inhibidores de tirosina quinasa.
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
NZ630589A (en) Methods of treating alzheimer’s disease and pharmaceutical compositions thereof
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
PH12015500063A1 (en) Azaindole derivatives which act as pi3k inhibitors
MX2015000965A (es) 4-metil-2,3,5,9,9b-pentaaza-ciclopenta [a] naftalenos.
JP2015107945A5 (enExample)
MX2014014969A (es) Combinacion de un inhibidor de la 17-alfa-hidroxilasa (c17,20-liasa) y un inhibidor especifico de la pi-3k para tratar una enfermedad tumoral.
MY183111A (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
JP2016509601A5 (enExample)
Furman et al. Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages
JP2015502973A5 (enExample)
TN2012000418A1 (en) Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
PH12013500545A1 (en) Oxadiazole inhibitors of leukotriene production
WO2011158110A3 (en) Cilostazol cocrystals and compositions
JP2014530204A5 (enExample)
JP2011500819A5 (enExample)
TN2012000619A1 (fr) Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent